ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 208 filers reported holding CONMED CORP in Q4 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of CONMED CORP
ValueSharesWeighting
Q4 2020$280,000
-97.4%
2,500
-98.3%
0.00%
-100.0%
Q2 2020$10,678,000
+148.3%
148,329
+97.5%
0.02%
+66.7%
Q1 2020$4,300,000
+40.3%
75,088
+174.0%
0.01%
+71.4%
Q4 2019$3,064,000
-81.4%
27,400
-86.1%
0.01%
-82.1%
Q1 2019$16,430,000
+12.7%
197,523
-13.0%
0.04%
+2.6%
Q4 2018$14,574,000
-19.3%
227,002
-0.5%
0.04%
-7.3%
Q3 2018$18,065,000
+160.3%
228,042
+140.5%
0.04%
+141.2%
Q2 2018$6,941,00094,8200.02%
Other shareholders
CONMED CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 190,000$24,858,0003.57%
Ranger Investment Management 253,789$33,203,0001.77%
EARNEST PARTNERS LLC 1,603,130$209,737,0001.28%
Penn Capital Management Company, LLC 92,086$12,048,0001.22%
Champlain Investment Partners, LLC 1,492,419$195,253,0000.94%
MOODY ALDRICH PARTNERS LLC 53,257$6,968,0000.88%
Hood River Capital Management LLC 215,384$28,179,0000.87%
OAK RIDGE INVESTMENTS LLC 71,880$9,404,0000.83%
WAFRA INC. 138,542$18,125,0000.66%
EPIQ PARTNERS, LLC 10,463$1,369,0000.63%
View complete list of CONMED CORP shareholders